Elite Pharma Inc (ELTP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
(Values in U.S. thousands)
| 03-2025 | 03-2024 | 03-2023 | 03-2022 | 03-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 11,315 | 7,106 | 7,832 | 8,535 | 3,193 |
| Receivables | 29,207 | 19,453 | 3,095 | 3,058 | 3,496 |
| Inventories | 16,240 | 12,931 | 9,551 | 6,741 | 5,013 |
| TOTAL | $57,739 | $40,014 | $21,510 | $18,861 | $12,195 |
| Non-Current Assets | |||||
| PPE Net | 10,327 | 10,175 | 10,426 | 5,953 | 6,649 |
| Intangibles | 5,638 | 6,341 | 6,341 | 6,634 | 6,634 |
| Other Non-Current Assets | 22,683 | 27,123 | 2,618 | 3,701 | 711 |
| TOTAL | $38,648 | $43,639 | $19,386 | $16,288 | $13,995 |
| Total Assets | $96,388 | $83,654 | $40,896 | $35,149 | $26,190 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 4,247 | 4,296 | 311 | 354 | 411 |
| Accounts payable and accrued liabilities | 2,958 | 2,714 | 2,447 | 1,431 | 930 |
| Accrued Expenses | 3,795 | 5,302 | 5,048 | 4,693 | 4,271 |
| TOTAL | $11,840 | $13,050 | $7,834 | $6,694 | $5,813 |
| Non-Current Liabilities | |||||
| Long Term Debt | 3,033 | 3,280 | 3,562 | 1,389 | 1,741 |
| Deferred Revenues | 6 | 13 | 13 | 13 | 13 |
| Other Non-Current Liabilities | 26,751 | 8,255 | 522 | 1,812 | 2,439 |
| TOTAL | $31,032 | $13,021 | $4,102 | $3,233 | $4,225 |
| Total Liabilities | $42,873 | $26,071 | $11,936 | $9,927 | $10,038 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,068,463 | 1,068,273 | 1,013,915 | 1,011,282 | 1,009,177 |
| Common Shares | 1,069 | 1,068 | 1,014 | 1,011 | 1,009 |
| Retained earnings | -120,704 | -116,389 | -136,498 | -140,060 | -148,958 |
| Other shareholders' equity | -307 | -307 | -307 | -307 | -307 |
| TOTAL | $53,515 | $57,583 | $28,960 | $25,222 | $16,152 |
| Total Liabilities And Equity | $96,388 | $83,654 | $40,896 | $35,149 | $26,190 |